Yamazawa (9993) · FactMitigated
Drugstore Business Segment Loss
First written in FY2019-Q2. 10 of 30 entries say "Worsened", first in FY2019-Q3. Latest entry: 2026-10-14.
30entries
9years
3from disclosures
How it moved
Same theme, other companies
Launch of the merchandise business and widening segment lossesA theme 2 companies write about · 2 as a headwind · 0 as a tailwind
Yamazawa moved to the "Worse" side of this theme in 2022.
0 other companies' latest entry also says "Mitigated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- 2026-10-14MitigatedEarnings
「Segment income or loss (△) 698 △31 7 674 5 680」
The drugstore business reduced its segment loss from ¥65 million in the previous period to ¥31 million, but remained loss-making. - FY2027-H1MitigatedAnnual report
「Segment profit or loss 698 △ 31 674 5 680」
The drugstore business reported a segment loss of ¥31 million, narrowing from a loss of ¥65 million in the same period of the previous year. However, it remains loss-making. - 2026-07-14MitigatedEarnings
「Net sales in the drugstore business were ¥3,396 million, up 4.6% year on year.」
The drugstore business moved from a segment loss of ¥22 million in the previous period to segment income of ¥9 million, eliminating the loss. - FY2026WorsenedAnnual report
「Segment profit or loss (△) 1,437 △ 100 △ 205 1,131 8 1,140」
The Drugstore Business reported a full-year segment loss of ¥100 million, turning from a segment profit of ¥37 million in the previous fiscal year to a loss. - 2026-04-20MitigatedRevision of earnings forecasts
「Segment income or loss (△) 1,439 △100 △205 1,133 8 1,142」
The drugstore business reduced its segment loss from ¥163 million to ¥100 million, but remained loss-making. - FY2026-H1MitigatedAnnual report
「Segment profit or loss (△) 738 △ 65 △ 81 591 4 595」
The Drugstore Business reported a segment loss of ¥65 million, narrowing from ¥127 million in the same period of the previous year. However, it remained loss-making. - FY2025-H1WorsenedAnnual report
「Segment loss △ 394 △ 127 △ 521 △ 165 △ 687 4 △ 682」
The Drugstore Business reported a segment loss of ¥127 million for the current interim consolidated accounting period, turning from a ¥36 million profit in the same period of the previous year to a loss. - FY2025-Q1WorsenedAnnual report
「Segment loss (△) △ 263 △ 60 △ 323 △ 87 △ 411 2 △ 408」
The Drugstore Business reported a segment loss of ¥60 million for the first quarter of the current consolidated fiscal year, turning from a ¥4 million profit in the same period of the previous year to a loss. - FY2024WorsenedAnnual report
「Segment profit 750 37 787 △ 172 615 10 625」
Full-year segment profit for the Drugstore Business was ¥37 million, down from ¥117 million in the previous fiscal year. - FY2024-Q3WorsenedAnnual report
「Segment profit or loss (△) 419 50 470 △ 36 434 7 441」
Cumulative segment profit for the Drugstore Business through the third quarter was ¥50 million, down from ¥92 million in the same period of the previous year. However, it increased from ¥36 million in the cumulative previous quarter. - FY2024-Q2WorsenedAnnual report
「Segment profit 412 36 449 78 527 5 532」
Cumulative segment profit for the Drugstore Business through the second quarter was ¥36 million, down from ¥49 million in the same period of the previous year. - FY2024-Q1Decrease in Drugstore Business Quarterly ProfitAnnual report
「Segment profit 23 4 28 48 76 2 78」
Segment profit for the Drugstore Business for the first quarter of the current consolidated fiscal year was ¥4 million, down from ¥9 million in the same period of the previous year. - FY2023Full-Year Segment Profit DisclosedAnnual report
「Segment profit 511 117 628 67 696 14 710」
The full-year segment information discloses drugstore business segment profit of ¥117 million. The business generated a profit, compared with a ¥5 million loss in the previous fiscal year. - FY2023-Q3Increase in Drugstore Business Segment ProfitAnnual report
「Segment profit 494 92 586 62 649 5 655」
Drugstore business segment profit in the cumulative third quarter of the current consolidated fiscal year was ¥92 million, up from ¥5 million in the same period of the previous year. - FY2023-Q2Increase in Drugstore Business Segment ProfitAnnual report
「Segment profit 579 49 628 56 685 △ 2 683」
Drugstore business segment profit in the cumulative second quarter of the current consolidated fiscal year was ¥49 million, up from ¥14 million in the same period of the previous year. - FY2023-Q1Continued Quarterly Profit GenerationAnnual report
「Segment profit 297 9 306 20 326 △ 11 314」
In the cumulative first quarter of the current consolidated fiscal year, the drugstore business recorded segment profit of ¥9 million. The business generated a quarterly profit, having recorded a segment loss in the previous consolidated fiscal year. - FY2022WorsenedAnnual report
「Segment profit or loss (△) 970 △ 5 964」
The drugstore business shifted from segment profit of ¥106 million in the same period of the previous year to a ¥5 million loss, resulting in a deterioration in its profit level. - FY2022-Q3WorsenedAnnual report
「Segment profit 504 5 510 74 584 26 611」
Drugstore business segment profit was ¥5 million, down from ¥149 million in the same period of the previous year. It also declined from ¥14 million in the cumulative second quarter, and the lower profit level is continuing. - FY2022-Q2Continued Decline in Drugstore Business Segment ProfitAnnual report
「Segment profit 480 14 495 66 561 17 579」
Drugstore business segment profit in the cumulative second quarter of the current consolidated fiscal year was ¥14 million, down from ¥106 million in the same period of the previous year. - FY2022-Q1Decrease in Drugstore Business Segment ProfitAnnual report
「Segment profit 498 9 508 21 529 9 538」
In the segment information, drugstore business segment profit declined from ¥20 million in the same period of the previous year to ¥9 million in the current period. Supermarket business segment profit also declined from ¥849 million to ¥498 million. - FY2021-Q3Increase in Drugstore Business Segment ProfitAnnual report
「Segment profit 1,461 149 1,610 126 1,737 30 1,768」
Drugstore business segment profit increased to ¥149 million from ¥106 million in the cumulative period through the previous quarter. The shift to profit from a ¥21 million loss in the same period of the previous year is continuing. - FY2021-Q2Continued Shift to Segment ProfitAnnual report
「Segment profit 1,243 106 1,349 109 1,458 19 1,477」
In the cumulative second quarter of the current consolidated fiscal year, the supermarket business recorded segment profit of ¥1,243 million and the drugstore business recorded segment profit of ¥106 million. The drugstore business shifted from a ¥4 million loss in the same period of the previous year to a profit. - FY2021-Q1Increase in Segment ProfitAnnual report
「Segment profit 849 20 870 58 929 9 938」
In the segment information, drugstore business segment profit increased from ¥5 million in the same period of the previous year to ¥20 million in the current period. - FY2020WorsenedAnnual report
「Segment profit or loss (△) 659 △ 130 529 68 598 28 627」
The drugstore business recorded a ¥130 million segment loss, with the loss widening from ¥40 million in the previous fiscal year. - FY2020-Q3Wider Drugstore Business LossAnnual report
「Segment profit or loss (△) 92 △ 21 71 52 123 21 145」
The drugstore business recorded a ¥21 million segment loss, with the loss widening from ¥4 million in the cumulative period through the previous quarter. However, the loss narrowed compared with the ¥40 million loss in the cumulative period of the same period of the previous year. - FY2020-Q2Narrower Drugstore Business LossAnnual report
「Segment profit or loss (△) 185 △ 4 180 48 229 14 244」
The drugstore business recorded a ¥4 million segment loss, narrowing from a ¥9 million loss in the same period of the previous year. - FY2020-Q1From segment loss to profitAnnual report
「Segment profit 125 5 131 15 147 7 154」
Drugstore business segment earnings improved from a ¥4 million loss in the same period of the previous year to a ¥5 million profit in the current period. - FY2019RestatedAnnual report
「Segment profit or loss (△) 245 △ 40 205 97 302 △ 82 220」
The full-year segment information also confirms a ¥40 million segment loss for the drugstore business. - FY2019-Q3WorsenedAnnual report
「Segment profit or loss (△) 205 △ 40 164 73 238 △ 61 176」
Drugstore business segment earnings deteriorated from a ¥42 million profit in the same period of the previous year to a ¥40 million loss. - FY2019-Q2First statedAnnual report
「Segment profit or loss (△) 193 △ 9 184 60 244 △ 41 202」
In the segment information, drugstore business segment profit declined from ¥29 million in the same period of the previous year to a ¥9 million loss in the current period.